A detailed history of Twin Capital Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Twin Capital Management Inc holds 50,918 shares of ABT stock, worth $5.87 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
50,918
Previous 46,868 8.64%
Holding current value
$5.87 Million
Previous $4.87 Million 19.2%
% of portfolio
0.68%
Previous 0.59%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$100.07 - $118.13 $405,283 - $478,426
4,050 Added 8.64%
50,918 $5.81 Million
Q2 2024

Aug 13, 2024

BUY
$100.73 - $112.44 $125,711 - $140,325
1,248 Added 2.74%
46,868 $4.87 Million
Q1 2024

May 13, 2024

BUY
$109.52 - $120.96 $318,046 - $351,267
2,904 Added 6.8%
45,620 $5.19 Million
Q4 2023

Jan 31, 2024

BUY
$90.19 - $110.4 $260,558 - $318,945
2,889 Added 7.25%
42,716 $4.7 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $262,516 - $314,975
-2,748 Reduced 6.45%
39,827 $3.86 Million
Q2 2023

Aug 07, 2023

BUY
$100.78 - $112.29 $495,636 - $552,242
4,918 Added 13.06%
42,575 $4.64 Million
Q1 2023

May 08, 2023

SELL
$96.86 - $114.01 $223,746 - $263,363
-2,310 Reduced 5.78%
37,657 $3.81 Million
Q4 2022

Jan 31, 2023

SELL
$95.06 - $111.52 $119,490 - $140,180
-1,257 Reduced 3.05%
39,967 $4.39 Million
Q3 2022

Oct 21, 2022

BUY
$96.76 - $112.03 $257,575 - $298,223
2,662 Added 6.9%
41,224 $3.99 Million
Q2 2022

Aug 02, 2022

SELL
$102.07 - $123.37 $67,978 - $82,164
-666 Reduced 1.7%
38,562 $4.19 Million
Q1 2022

May 06, 2022

BUY
$114.02 - $139.04 $4.47 Million - $5.45 Million
39,228 New
39,228 $4.64 Million
Q2 2021

Aug 09, 2021

SELL
$105.79 - $124.53 $891,280 - $1.05 Million
-8,425 Closed
0 $0
Q1 2021

May 06, 2021

SELL
$108.84 - $128.23 $127,342 - $150,029
-1,170 Reduced 12.19%
8,425 $1.01 Million
Q4 2020

Feb 11, 2021

SELL
$105.0 - $114.42 $25,410 - $27,689
-242 Reduced 2.46%
9,595 $1.05 Million
Q3 2020

Nov 05, 2020

SELL
$91.64 - $111.29 $10,446 - $12,687
-114 Reduced 1.15%
9,837 $1.07 Million
Q2 2020

Aug 04, 2020

BUY
$76.57 - $98.0 $761,948 - $975,198
9,951 New
9,951 $910,000
Q3 2017

Nov 09, 2017

SELL
$48.06 - $53.64 $4.39 Million - $4.89 Million
-91,250 Closed
0 $0
Q2 2017

Aug 07, 2017

BUY
N/A
91,250
91,250 $4.44 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $202B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Twin Capital Management Inc Portfolio

Follow Twin Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Twin Capital Management Inc with notifications on news.